261 related articles for article (PubMed ID: 27183205)
1. Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.
Lin LL; Huang CC; Wu CL; Wu MT; Hsu WM; Chuang JH
Lab Invest; 2016 Jul; 96(7):719-30. PubMed ID: 27183205
[TBL] [Abstract][Full Text] [Related]
2. Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells.
Chuang JH; Chuang HC; Huang CC; Wu CL; Du YY; Kung ML; Chen CH; Chen SC; Tai MH
J Biomed Sci; 2011 Aug; 18(1):65. PubMed ID: 21861882
[TBL] [Abstract][Full Text] [Related]
3. MDA5 complements TLR3 in suppression of neuroblastoma.
Hsu WM; Huang CC; Lee HY; Wu PY; Wu MT; Chuang HC; Lin LL; Chuang JH
Oncotarget; 2015 Sep; 6(28):24935-46. PubMed ID: 26208481
[TBL] [Abstract][Full Text] [Related]
4. Preferential involvement of mitochondria in Toll-like receptor 3 agonist-induced neuroblastoma cell apoptosis, but not in inhibition of cell growth.
Chuang JH; Lin TK; Tai MH; Liou CW; Huang ST; Wu CL; Lin HY; Wang PW
Apoptosis; 2012 Apr; 17(4):335-48. PubMed ID: 22187010
[TBL] [Abstract][Full Text] [Related]
5. Innate immune sensor laboratory of genetics and physiology 2 suppresses tumor cell growth and functions as a prognostic marker in neuroblastoma.
Lin LL; Huang CC; Wu MT; Hsu WM; Chuang JH
Cancer Sci; 2018 Nov; 109(11):3494-3502. PubMed ID: 30179292
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response.
Chuang HC; Lin HY; Liao PL; Huang CC; Lin LL; Hsu WM; Chuang JH
Lab Invest; 2020 Apr; 100(4):606-618. PubMed ID: 31857701
[TBL] [Abstract][Full Text] [Related]
7. Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice.
Huang CC; Wang SY; Lin LL; Wang PW; Chen TY; Hsu WM; Lin TK; Liou CW; Chuang JH
Dis Model Mech; 2015 Oct; 8(10):1247-54. PubMed ID: 26398947
[TBL] [Abstract][Full Text] [Related]
8. IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner.
Chiba Y; Mizoguchi I; Mitobe K; Higuchi K; Nagai H; Nishigori C; Mizuguchi J; Yoshimoto T
PLoS One; 2013; 8(10):e76159. PubMed ID: 24155891
[TBL] [Abstract][Full Text] [Related]
9. Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.
Wang SS; Hsiao R; Limpar MM; Lomahan S; Tran TA; Maloney NJ; Ikegaki N; Tang XX
Int J Mol Med; 2014 Jan; 33(1):35-42. PubMed ID: 24190252
[TBL] [Abstract][Full Text] [Related]
10. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
11. Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification.
Roy Choudhury S; Karmakar S; Banik NL; Ray SK
Invest New Drugs; 2010 Dec; 28(6):812-24. PubMed ID: 19777160
[TBL] [Abstract][Full Text] [Related]
12. Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells.
Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
Cell Death Dis; 2013 Jan; 4(1):e479. PubMed ID: 23370279
[TBL] [Abstract][Full Text] [Related]
13. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
[TBL] [Abstract][Full Text] [Related]
14. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
15. Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness.
Bugge M; Bergstrom B; Eide OK; Solli H; Kjønstad IF; Stenvik J; Espevik T; Nilsen NJ
J Biol Chem; 2017 Sep; 292(37):15408-15425. PubMed ID: 28717003
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 3 expression inhibits cell invasion and migration and predicts a favorable prognosis in neuroblastoma.
Hsu WM; Huang CC; Wu PY; Lee H; Huang MC; Tai MH; Chuang JH
Cancer Lett; 2013 Aug; 336(2):338-46. PubMed ID: 23541683
[TBL] [Abstract][Full Text] [Related]
17. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG
FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Reactive Oxygen Species in TRIF-Dependent Toll-like Receptor 3 Signaling in Bronchial Epithelial Cells against Viral Infection.
Chu GE; Park JY; Park CH; Cho WG
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203397
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ promotes double-stranded RNA-induced TLR3-dependent apoptosis via upregulation of transcription factor Runx3 in airway epithelial cells.
Gan H; Hao Q; Idell S; Tang H
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1101-L1112. PubMed ID: 27793801
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3-UNC93B1-IFN-β signaling axis in paclitaxel-resistant colon cancer.
Zhao J; Xue Y; Pan Y; Yao A; Wang G; Li D; Wang T; Zhao S; Hou Y
J Cell Physiol; 2019 May; 234(5):7051-7061. PubMed ID: 30387134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
